Failure of beta-cell function to compensate lack of insulin action in hyperuricemic subjects

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 6, 2009, Pages 535-541

  Simental Mendía, Luis E ^a,b   Rodríguez Morán, Martha ^a,b   Guerrero Romero, Fernando ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Research Group on Diabetes and Chronic Illnesses   (Mexico)

Author keywords

Beta cell function; IGT; Insulin sensitivity; Uric acid

Indexed keywords

ADULT; AGED; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERURICEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ADULT; AGED; AGING; ALGORITHMS; AREA UNDER CURVE; BLOOD GLUCOSE; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERURICEMIA; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; REGRESSION ANALYSIS; SEX CHARACTERISTICS; STATISTICS, NONPARAMETRIC; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 70350599385     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.988     Document Type: Article

References (32)

1. Bonora E, Targher G, Zenere MB, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 1996; 20: 975-980. (Pubitemid 26366450)
2. Agamah ES, Srinivasan SR, Webber LS, Berenson GS. Serum uric acid and its relation to cardiovascular disease risk factors in children and young adults from a biracial community: the Bogalusa Heart Study. J Lab Clin Med 1991; 118: 241-249.
3. Modan A, Halkin H, Karasik A, Lusky A. Elevated serum uric acid: a facet of hyperinsulinaemia. Diabetologia 1987; 30: 713-718. (Pubitemid 17155777)
4. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991; 266: 3008-3011.
5. Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78: 25-29.
6. Schmitz O, Alberti KG, Christensen NJ, et al. Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique. Metabolism 1985; 34: 465-473. (Pubitemid 15063898)
7. Niskanen L, Laaksonen DE, Lindstrom J, et al. Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabetes Care 2006; 29: 709-711. (Pubitemid 44115381)
8. Carnethon MR, Fortmann SP, Palaniappan L, Duncan BB, Schmidt MI, Chambless LE. Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol 2003; 158: 1058-1067.
9. Dehghan A, van Hoek M, Sijbrands E, Hofman A, Witteman J. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008; 31: 361-362. (Pubitemid 351213351)
10. Bergman RN. Toward physiological understanding of glucose tolerance. Diabetes 1989; 38: 1512-1517.
11. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects: evidence for a hyperbolic function. Diabetes 1993; 42: 1663-1672.
12. Guerrero F, Rodriguez M. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus. Eur J Clin Invest 2006; 36: 796-802. (Pubitemid 44569968)
13. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446. (Pubitemid 27517978)
14. Bergman RN, Ader M, Huecking K, van Citters G. Accurate assessment of beta-cell function. The hyperbolic correction. Diabetes 2002; 51(Suppl 1): S212-S220. (Pubitemid 34761518)
15. Belfiore F, Lannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 1998; 63: 134-141. (Pubitemid 28453331)
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
17. Bomalaski JS, Holtsberg FW, Ensor CM, Clark MA. Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies. J Rheumatol 2002; 29: 1942-1949.
18. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1187.
19. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
20. Shargel L, Wu-Pong S, Yu ABC. Review of mathematical fundamentals. In Applied Biopharmaceutics and Pharmacokinetics (5th edn). McGraw-Hill: New York, 2004; 21-51.
21. Santos RD, Nasir K, Orakzai R, Meneghelo RS, Carvalho JA, Blumenthal RS. Relation of uric acid levels to presence of coronary artery calcium detected by electron beam tomography in men free of symptomatic myocardial ischemia with versus without the metabolic syndrome. Am J Cardiol 2007; 99: 42-45. (Pubitemid 44969336)
22. Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007; 115: 2526-2532. (Pubitemid 46763226)
23. Onat A, Uyarel H, Hergenc G, et al. Serum uric acid is a determinant ofmetabolic syndrome in a population-based study. Am J Hypertens 2006; 19: 1055-1062. (Pubitemid 44485960)
24. Conen D, Wietlisbach V, Bovet P, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004; 4: 9-11. (Pubitemid 38729439)
25. Sinagra D, Greco D, Scarpitta AM, Bonaventura V. Serum uric acid, insulin secretion and resistance in nonhyperuricemic and hyperuricemic obese female subjects. Int J Obes Relat Metab Disord 1996; 20: 1041-1043. (Pubitemid 26366459)
26. Clausen JO, Borch-Johnsen K, Ibsen H, Pedersen O. Analysis of the relationship between fasting serum uric acid and the insulin sensitivity index in a population-based sample of 380 young healthy Caucasians. Eur J Endocrinol 1998; 138: 63-69. (Pubitemid 28078811)
27. Costa A, Iguala I, Bedini J, Quinto L, Conget I. Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism 2002; 51: 372-375. (Pubitemid 34232641)
28. Rho YH, Woo JH, Choi SJ, Lee YH, Ji JD, Song GG. Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: results from a single hospital database. Metabolism 2008; 57: 71-76.
29. Ebrahimpour P, Fakhrzadeh H, Heshmat R, Bandarian F, Larijani B. Serum uric acid levels and risk of metabolic syndrome in healthy adults. Endocr Pract 2008; 14: 298-304.
30. Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78: 25-29.
31. Lin KC, Tsai ST, Lin HY, Chou P. Different progressions of hyperglycemia and diabetes among hyperuricemic men and women in the kinmen study. J Rheumatol 2004; 31: 1159-1165. (Pubitemid 38715893)
32. Fang J, Alderman MH. Serum Uric Acid and Cardiovascular Mortality. The NHANES I Epidemiologic Follow-up Study, 1971-1992. JAMA 2000; 283: 2404-2410.